Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Economics Change patient management

28 Publications found

Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease.

b

Therapeutic drug monitoring

June 1, 2023

p Therapeutic drug monitoring

c Change patient management Economics Observational
Retrospective study assessing outcomes in cardiac surgery after implementation of Quantra.

b

Journal of cardiothoracic surgery

April 17, 2023

p Viscoelastic Testing

c Change patient management Economics Observational
Thromboelastometry-guided haemostatic resuscitation in severely injured patients: a propensity score-matched study.

b

Critical care (London, England)

April 13, 2023

p Viscoelastic Testing

c Change patient management Clinical outcomes Economics Highlighted Observational
A systematic review: Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes.

b

Endocrinology, diabetes & metabolism

November 1, 2022

p Diabetes

c Change patient management Economics RCT
Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?

b

Inflammatory intestinal diseases

January 1, 2022

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics Observational Operational efficiencies Patient-centeredness
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.

b

Rheumatology and therapy

September 1, 2021

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics RCT
Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savings.

b

Internal medicine journal

May 1, 2021

p Therapeutic drug monitoring

c Change patient management Economics Observational
Avoiding insufficient therapies and overdosing with co-reporting eGFRs (estimated glomerular filtration rate) for personalized drug therapy and improved outcomes – a simulation of the financial benefits.

b

EJIFCC

February 1, 2021

p Kidney Disease

c Change patient management Economics Observational
Cost-effectiveness of financial incentives to improve glycemic control in adults with diabetes: A pilot randomized controlled trial.

b

PloS one

January 1, 2021

p Diabetes

c Change patient management Clinical outcomes Economics RCT
Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver Disease.

b

The journal of applied laboratory medicine

September 1, 2020

p Liver Disease

c Change patient management Clinical outcomes Economics Observational Patient-centeredness Safety